Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-021624
Filing Date
2022-03-30
Accepted
2022-03-30 17:15:56
Documents
1
Period of Report
2022-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3945
  Complete submission text file 0001209191-22-021624.txt   5409
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Issuer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105
Business Address
Thornton Michael Milos (Reporting) CIK: 0001706297 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37969 | Film No.: 22787657